- Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer
-
Akkhasutthikun P, Kaewsapsak P, Nimsamer P, Klomkliew P, Visedthorn S, Chanchaem P, Teerapakpinyo C, Payungporn S, Luangdilok S
- KMID: 2554336
- Cancer Res Treat.
- 2024 Apr;56(2):455-463.
- doi: 10.4143/crt.2023.1108
Purpose The epidermal growth factor receptor (EGFR) mutation is a widely prevalent oncogene driver in non–small cell lung cancer (NSCLC) in East Asia. The detection of EGFR mutations is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
-
Luangdilok S, Samarnthai N, Korphaisarn K
- KMID: 2176130
- J Breast Cancer.
- 2014 Dec;17(4):376-385.
- doi: 10.4048/jbc.2014.17.4.376
PURPOSE: We aimed to determine the rate of pathological complete response (pCR), clinicopathological factors associated with pCR, and clinical outcomes following neoadjuvant chemotherapy in locally advanced breast cancer. METHODS: Medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
